Blog: You, us, everyone

Welcome to our blog – a place to discuss and exchange thoughts and ideas about iX-7 Asset Management SA, the stock markets and all matters relating to wealth management.


Article
Tuesday, July 1, 2025 by Christoph Schmid|Comment 0
within category Sandoz,Strat_Bord,Pharmaceuticals,generic drugs,biosimilars,Generics,Biosimilars,Innovation,Sustainability,Global Reach

Sandoz Group AG is a leading global provider of generic pharmaceuticals and biosimilars, headquartered in Basel, Switzerland. Founded in 1886, Sandoz was a division of Novartis until its spin-off in October 2023. The company operates in over 160 countries, offering a portfolio of approximately 1,500 products across various therapeutic areas, including oncology, immunology, cardiology, and ophthalmology. Sandoz is committed to enhancing patient access to high-quality medicines through innovation and sustainability initiatives.

Comments
Not commented yet? Be the first to post a comment.
Current pageTotal pages 0
Comments per page
select
Add a comment
Author:
Email: Help
Related articles
Sunday, June 29, 2025
AstraZeneca PLC (Ticker: AZN.L / AZN) is a British-Swedish multinational pharmaceutical and biotechnology company, and one of the largest and most innovative players in the global healthcare sector. …
More …

Saturday, October 15, 2022
Deux bonnes nouvelles pour le laboratoire. Les autorités de santé ont approuvé les vaccins de rappel adaptés au variant Omicron pour les enfants dès cinq ans. Et la pharma annonce s'associer à Merck …
More …

Monday, February 16, 2015
Speed read New growth in cases: Measles was officially eliminated in the Western world in the late 1990s, but a growing number of cases have been reported i…
More …
iX-7 Asset Management SA, access to financial information is a right. Knowledge is power.